Appointment of Company Secretary and Compliance Officer w.e.f. 28.11.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals announced two key board-level appointments effective November 28, 2025. Ms. Pooja Narendra Sanghavi has been appointed as an Additional Director (Non-Executive, Independent) for a five-year term, subject to shareholder approval. Ms. Vaishnavi Sahu, an Associate Member of ICSI, has been appointed as the Company Secretary and Compliance Officer. Both appointments were recommended by the Nomination and Remuneration Committee and approved by the Board. Neither appointee is related to any existing directors on the board.
These are routine governance strengthening moves. The new independent director brings strong corporate law and SEBI compliance expertise, while the dedicated Company Secretary should improve regulatory compliance. No material impact on shareholders or stock price is expected.